Clinical Trial

The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

Name: The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX) — clinical trial record (NCT07512856)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.

Trial Details

NCT Number	NCT07512856
Lead Sponsor	Institute of HIV Research and Innovation Foundation, Thailand
Conditions	HIV Prevention, Substance Use, Mental Health Disorders, Sexually Transmitted Infections (STIs), Chemsex
Enrollment	140 participants
Start Date	2024-02-01
Primary Completion	2027-02-01 (estimated)
Study Completion	2028-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-06